Blood and urine metabolomics in children with autism spectrum disorder: biomarker discovery and clinical translation within a multi-pathway convergence framework
Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by deficits in social communication and restricted, repetitive behaviors, and is diagnosed in an increasing proportion of children worldwide. Diagnosis is currently based on standardized behavioral observation and developmental history, and no validated biological marker is yet available for routine clinical use.…
Read original article on Frontiers in Psychiatry | New and Recent Articles →Related news
-
Having a Bad Day? Here Are 21 Things You Can Do to Turn It Around
Sweden
-
Beyond emotional symptoms: multidomain routine outcome monitoring in psychiatric outpatient care
Switzerland
-
A real diagnosis or just a Western trend? Navigating adult ADHD diagnosis and treatment in Saudi Arabia
Switzerland
-
Psychological safety and organizational silence in Turkish schools
Switzerland
-
Beyond monotherapy: sex- and age-stratified pharmacovigilance of blonanserin adverse events focusing on drug-drug interactions
Switzerland
-
Age-stratified reporting patterns of medications and suicide-related events in FAERS
Switzerland
-
Exploring the association between heart rate variability and self-efficacy: A secondary analysis of a cross-sectional pilot study
Switzerland
-
A shared core, distinct network organization: urban–rural variation in ADHD–aggression networks and simulated intervention profiles among Chinese college students
Switzerland